Yiqiu Liu

机构：Hong Kong University of Science and Technology, Jiangsu Province Hospital, Nanjing Medical University, South China University of Technology · ORCID：0000-0002-7575-1533

发表论文 25 篇 · 总被引 410 次 · h-index 8

代表论文

• Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis (2021 · Oncogenesis · 被引 187)
• MYC dysfunction modulates stemness and tumorigenesis in breast cancer (2020 · International Journal of Biological Sciences · 被引 82)
• Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer (2024 · Acta Pharmaceutica Sinica B · 被引 28)
• The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy (2021 · Journal of Inflammation Research · 被引 26)
• Tumor-derived extracellular vesicles as a biomarker for breast cancer diagnosis and metastasis monitoring (2024 · iScience · 被引 17)
• Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer (2022 · Chinese Medical Journal · 被引 16)